1. Home
  2. BLDR vs VTRS Comparison

BLDR vs VTRS Comparison

Compare BLDR & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

HOLD

Current Price

$112.71

Market Cap

13.9B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.80

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDR
VTRS
Founded
1998
1961
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
12.0B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
BLDR
VTRS
Price
$112.71
$10.80
Analyst Decision
Buy
Hold
Analyst Count
18
6
Target Price
$143.89
$11.17
AVG Volume (30 Days)
2.4M
9.0M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
4.45%
EPS Growth
N/A
N/A
EPS
5.26
N/A
Revenue
$15,653,056,000.00
$14,124,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.28
$1.61
P/E Ratio
$21.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$94.35
$6.85
52 Week High
$187.22
$13.25

Technical Indicators

Market Signals
Indicator
BLDR
VTRS
Relative Strength Index (RSI) 54.33 57.69
Support Level $109.75 $10.49
Resistance Level $114.67 $10.73
Average True Range (ATR) 4.16 0.25
MACD 2.15 -0.00
Stochastic Oscillator 89.57 62.02

Price Performance

Historical Comparison
BLDR
VTRS

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: